
How similar are your biosimilars?
Somru BioScience Inc. has developed the Intelli.b™ platform for comparability testing of biosimilars at the molecular level, meeting the intent of FDA guidance for fingerprint-like analysis.
Read moreUltra-sensitive immunoassay solutions for
low-abundance biomarker and impurity detection

The rise of biosimilars has provided challenges and opportunities in equal measure for biotechnology, biopharmaceutical and bioanalytical contract research organizations (CROs). Somru BioScience Inc. has developed a portfolio of reagents, tools, solutions and a knowledge database that will enable companies to capitalize on biosimilar opportunities. We provide comprehensive expertise and solutions to reduce both the time and cost of your biosimilar development programs.
Read moreStay updated with the latest insights, research developments, and industry news from Somru BioScience Inc. Explore our expert perspectives on biosimilars, immunogenicity, biomarker testing, and cutting-edge biopharmaceutical innovations.

Somru BioScience Inc. has developed the Intelli.b™ platform for comparability testing of biosimilars at the molecular level, meeting the intent of FDA guidance for fingerprint-like analysis.
Read more
Somru BioScience Inc. offers high quality, sensitive and robust off-the-shelf ELISA kits for the measurement of anti-drug antibodies (i.e. both anti-innovator and anti-biosimilar) in biological matrices.
Read more
Biomarkers have become an integral part of the decision-making process not only in the personalized drug development process, but also in biosimilar and biobetter drug development.
Read moreExplore our comprehensive portfolio of biopharmaceutical products and solutions. From advanced antibody detection kits to cutting-edge biomarker assays, Somru BioScience Inc. provides the tools you need to accelerate your drug development and research programs.
Join us for our comprehensive seminar series exploring the bioanalytical challenges and innovative solutions in biosimilar development. Biosimilars represent a critical advancement in making biologic
A pioneer and a prodigy from PEI's bioscience business community are the inaugural winners of the Synapse Innovator Awards. "There are world-class success stories that have stemmed directly from indiv